Regional cerebral glucose metabolism in patients with Parkinson's disease with or without dementia
- PMID: 1489634
- DOI: 10.1007/BF03164661
Regional cerebral glucose metabolism in patients with Parkinson's disease with or without dementia
Abstract
By means of positron emission tomography, the cerebral glucose metabolism in 5 patients with Parkinson's disease with dementia was compared with that in 9 patients without dementia, and that in 5 normal volunteers. The metabolic rates for glucose were measured by placing one hundred regions of interest. In the demented patients, cerebral glucose metabolism was diffusely decreased compared with that of the non-demented patients and the normal controls. The most significant decrease in glucose metabolism was observed in the angular gyrus (49.7% of the normal controls). The glucose metabolism in the cingulate, pre- and postcentral, occipital and subcortical regions was relatively spared (62.1 to 85.5% of the normal controls). In the patients without dementia, the glucose metabolism in each region was not significantly different from that in the normal controls. These results suggest that diffuse glucose hypometabolism in the cerebral cortex may correlate with that of patients with Parkinson's disease with dementia.
Similar articles
-
[18F-fluorodeoxyglucose positron emission tomography in Parkinson's disease].Nihon Rinsho. 1997 Jan;55(1):222-6. Nihon Rinsho. 1997. PMID: 9014454 Review. Japanese.
-
[Cerebral glucose metabolism in dementia (PET-FDG study)].Rinsho Hoshasen. 1989 Oct;34(11):1343-8. Rinsho Hoshasen. 1989. PMID: 2601096 Japanese.
-
Cerebral glucose metabolism in Parkinson's disease with and without dementia.Arch Neurol. 1992 Dec;49(12):1262-8. doi: 10.1001/archneur.1992.00530360060019. Arch Neurol. 1992. PMID: 1449406
-
Patterns of local cerebral glucose utilization determined in Parkinson's disease by the [18F]fluorodeoxyglucose method.Ann Neurol. 1984 May;15(5):419-24. doi: 10.1002/ana.410150504. Ann Neurol. 1984. PMID: 6610384
-
Positron emission tomography imaging of regional cerebral glucose metabolism.Semin Nucl Med. 1986 Jan;16(1):2-34. doi: 10.1016/s0001-2998(86)80002-2. Semin Nucl Med. 1986. PMID: 2935938 Review.
Cited by
-
Three-dimensional surface display of brain perfusion with 123I-IMP in Parkinson's disease.Neuroradiology. 1994 May;36(4):276-80. doi: 10.1007/BF00593259. Neuroradiology. 1994. PMID: 8065570
-
Clinical utility of FDG PET in Parkinson's disease and atypical parkinsonism associated with dementia.Eur J Nucl Med Mol Imaging. 2018 Jul;45(9):1534-1545. doi: 10.1007/s00259-018-4031-2. Epub 2018 May 19. Eur J Nucl Med Mol Imaging. 2018. PMID: 29779045 Free PMC article. Review.
-
Microglia, amyloid, and glucose metabolism in Parkinson's disease with and without dementia.Neuropsychopharmacology. 2013 May;38(6):938-49. doi: 10.1038/npp.2012.255. Epub 2012 Dec 6. Neuropsychopharmacology. 2013. PMID: 23303049 Free PMC article.
-
Brain Network and Abnormal Hemispheric Asymmetry Analyses to Explore the Marginal Differences in Glucose Metabolic Distributions Among Alzheimer's Disease, Parkinson's Disease Dementia, and Lewy Body Dementia.Front Neurol. 2019 Apr 12;10:369. doi: 10.3389/fneur.2019.00369. eCollection 2019. Front Neurol. 2019. PMID: 31031697 Free PMC article.
-
Beneficial effects of nicotine, cotinine and its metabolites as potential agents for Parkinson's disease.Front Aging Neurosci. 2015 Jan 9;6:340. doi: 10.3389/fnagi.2014.00340. eCollection 2014. Front Aging Neurosci. 2015. PMID: 25620929 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical